Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cardiovascular Research|September 12, 2006
Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytesYao-Jen Liang, Ling-Ping Lai, Bao-Wei Wang, et al.
European Journal of Pharmacology|November 23, 2017
Adenine accelerated the diabetic wound healing by PPAR delta and angiogenic regulationJyh-Gang Leu, Ming-Hsing Chiang, Chao-Yi Chen, et al.
Diabetes/Metabolism Research and Reviews|June 29, 2010
Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cellsYao-Jen Liang, Jhin-Hao Jian, Yuan-Chun Liu, et al.
Life (Basel, Switzerland)|December 24, 2021
The Cell Protective Effect of Adenine on Hypoxia-Reoxygenation Injury through PPAR Delta ActivationJyh-Gang Leu, Chien-Mei Wang, Chao-Yi Chen, et al.
International Journal of Medical Sciences|March 5, 2016
Endothelial Progenitor Cells Predict Long-Term Mortality in Hemodialysis PatientsChien-Lin Lu, Jyh-Gang Leu, Wen-Chih Liu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 13, 2011
The effects of gold nanoparticles in wound healing with antioxidant epigallocatechin gallate and α-lipoic acidJyh-Gang Leu, Siang-An Chen, Han-Min Chen, et al.
Life (Basel, Switzerland)|April 23, 2022
Topical Application of Antrodia cinnamomea Ointment in Diabetic Wound HealingRuey-Chih Su, Jyh-Gang Leu, Yuan-Hsin Chen, et al.
International Journal of Cardiology|April 28, 2009
Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cellsYao-Jen Liang, Yuan-Chun Liu, Chao-Yi Chen, et al.
European Journal of Pharmacology|July 6, 2010
Peroxisome proliferator-activated receptor delta agonists attenuated the C-reactive protein-induced pro-inflammation in cardiomyocytes and H9c2 cardiomyoblastsYao-Jen Liang, Chao-Yi Chen, Shiow-Jen Juang, et al.
Plos One|March 3, 2022
Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trialChien-Te Lee, Chin-Chan Lee, Ming-Ju Wu, et al.
Pageof 5